UNSPSC 51281662: Paromomycin i

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H45N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61JJC8N5ZK, chemically known as diamino-2,6-dideoxy-.beta.-l-idopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2-amino-2-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxystreptamine, but more generally known as paromomycin i, which bears US NIH Compound Identifier 4689.

European Medicines Agency schedules paromomycin i or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09630MIG. Most nations, for tariff purposes, schedule paromomycin i under HS 29419000. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N.

UNSPSC 51281662 Paromomycin i is a Commodity code that nominally identifies a specific pharmaceutical product, but the recent state and local solicitations tagged under it diverge significantly from this scope. The code's recent activity reflects broader procurement of pharmaceutical products and medical supplies rather than paromomycin specifically. State and local governments posting under this code are soliciting generic multi-source pharmaceuticals, over-the-counter products, naloxone and drug deactivation systems, and emergency medical supplies. Issuing bodies include state health and human services agencies (Texas Health and Human Services Commission, Minnesota Department of Administration), county health departments (Seminole County, Florida), and municipal fire and rescue divisions (City of Tampa Fire Department). The procurement activity spans competitive bidding processes, requests for information to gather vendor capability intelligence, and formal RFP mechanisms to establish multi-award pharmaceutical supply agreements.

Recent activity concentrates in Texas, Minnesota (serving multistate cooperative purchasing), and Florida. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities, including Oregon, requiring vendors to supply through three authorized wholesalers and meet cGMP and Drug Supply Chain Security Act compliance. Seminole County, Florida posted an IFB (due July 26, 2023, but recently reposted June 30, 2026) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The City of Tampa's Purchasing Department issued an IFB in March 2026 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000. The Texas Health and Human Services Commission posted an RFI in April 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, exploring vendor capacity for direct contracting models outside traditional pharmacy benefit manager arrangements.